Habibi et al., 2021 - Google Patents
A safe and effective sample collection method for assessment of SARS-CoV-2 in aerosol samplesHabibi et al., 2021
View HTML- Document ID
- 209282321673330518
- Author
- Habibi N
- Behbehani M
- Uddin S
- Al-Salameen F
- Shajan A
- Zakir F
- Publication year
- Publication venue
- Environmental resilience and transformation in times of COVID-19
External Links
Snippet
The role of airborne particles in spread of remains largely unexplored. It has been speculated that the novel corona virus can survive for extended periods in aerosols and its interaction with other viral communities is responsible for additional virulence and infectivity …
- 239000000443 aerosol 0 title abstract description 51
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6888—Hybridisation probes for detection or identification of organisms
- C12Q1/689—Hybridisation probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Moore et al. | Detection of SARS-CoV-2 within the healthcare environment: a multi-centre study conducted during the first wave of the COVID-19 outbreak in England | |
Zhou et al. | Breath-, air-and surface-borne SARS-CoV-2 in hospitals | |
Feng et al. | Multi-route transmission potential of SARS-CoV-2 in healthcare facilities | |
Santarpia et al. | Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care | |
Nissen et al. | Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards | |
Gonçalves et al. | Surface contamination with SARS-CoV-2: A systematic review | |
Rodríguez et al. | Are the Portable Air Cleaners (PAC) really effective to terminate airborne SARS-CoV-2? | |
Habibi et al. | A safe and effective sample collection method for assessment of SARS-CoV-2 in aerosol samples | |
Wu et al. | Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019 | |
Yang et al. | Concentrations and size distributions of airborne influenza A viruses measured indoors at a health centre, a day-care centre and on aeroplanes | |
Kim et al. | Evaluation of biosecurity measures to prevent indirect transmission of porcine epidemic diarrhea virus | |
Passos et al. | Exploratory assessment of the occurrence of SARS-CoV-2 in aerosols in hospital facilities and public spaces of a metropolitan center in Brazil | |
Martinez et al. | Detection, survival and infectious potential of Mycobacterium tuberculosis in the environment: a review of the evidence and epidemiological implications | |
Zhang et al. | Role of viral bioaerosols in nosocomial infections and measures for prevention and control | |
Dumont-Leblond et al. | Positive no-touch surfaces and undetectable SARS-CoV-2 aerosols in long-term care facilities: an attempt to understand the contributing factors and the importance of timing in air sampling campaigns | |
Shankar et al. | SARS-CoV-2 in residential rooms of two self-isolating persons with COVID-19 | |
Brown et al. | Influenza virus survival in aerosols and estimates of viable virus loss resulting from aerosolization and air-sampling | |
Vass et al. | Viable SARS-CoV-2 Delta variant detected in aerosols in a residential setting with a self-isolating college student with COVID-19 | |
Ge et al. | Evaluation of disinfection procedures in a designated hospital for COVID-19 | |
Tang et al. | Aerosol-transmitted infections—a new consideration for public health and infection control teams | |
Dubey et al. | Evidence of the presence of SARS‐CoV‐2 virus in atmospheric air and surfaces of a dedicated COVID hospital | |
Rufino de Sousa et al. | Detection and isolation of airborne SARS‐CoV‐2 in a hospital setting | |
Burgos-Ramos et al. | Is hydrogen peroxide an effective mouthwash for reducing the viral load of SARS-CoV-2 in dental clinics? | |
Wan et al. | Polymerase chain reaction used for the detection of airborne Mycobacterium tuberculosis in health care settings | |
Nagle et al. | Environmental SARS-CoV-2 contamination in hospital rooms of patients with acute COVID-19 |